Recent Advances in Targeted Therapies & Clinical Trial Analysis, 2018 Study - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Dec 17, 2018--The “Recent Advances in Targeted Therapies” report has been added to ResearchAndMarkets.com’s offering.
The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across targeted treatment strategies. High impact diseases such as hemophilia B, autism spectrum disorder, Alzheimer’s disease, and cancer are highlighted. The corresponding clinical trials scenario is also depicted.
Key Topics Covered:
Innovations in Targeted Treatment StrategiesAdeno-associated Virus Therapy Shows Promising Results in Hemophilia B Patients Uncovering the Role of Gut Microbiome in Autism Spectrum Disorder Novel Antibody Treatment for Alzheimer’s Disease Selectively Targeting Cancer Genes
Clinical Trial Analysis and Key ContactsClinical Trial Analysis for Loxo Oncology Inc.’s Candidates Key Contacts
For more information about this report visit https://www.researchandmarkets.com/research/bmmnsj/recent_advances?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005263/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/17/2018 04:25 AM/DISC: 12/17/2018 04:26 AM